Navidea Biopharmaceuticals, Inc. (NAVB) has a market capitalization of $10.01K and trades at $0.00. The 52-week range is 0.000099999997-0.04.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.59, annual revenue of $65.65K.
The stock has a beta of 1.80, operates in the Healthcare sector.
